Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Suzhou Chunghwa Chemical & Pharmaceutical Industrial Co., Ltd. (SCCPC) is a prominent pharmaceutical manufacturer based in Suzhou, China, and a key subsidiary of the Taiwan-based China Chemical & Pharmaceutical Group (CCPG). Established in 1993, the company specializes in the development and production of a diverse portfolio of generic drugs, including antibiotics, cardiovascular treatments, and medications for chronic metabolic and neurological conditions. SCCPC operates large-scale, GMP-certified manufacturing facilities and provides integrated CDMO and CRO services to international pharmaceutical partners. The company is recognized for its extensive commercial reach, with its products distributed to over 12,000 hospitals across mainland China. It leverages the research and development capabilities of its parent group to bring high-quality, affordable medicines to the Chinese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SCCPC.